Centiva Capital LP Buys Shares of 100,000 Translational Development Acquisition Corp. (NASDAQ:TDACU)

Centiva Capital LP purchased a new position in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 100,000 shares of the company’s stock, valued at approximately $1,844,000.

A number of other hedge funds have also made changes to their positions in TDACU. AQR Arbitrage LLC acquired a new stake in shares of Translational Development Acquisition during the fourth quarter worth $27,383,000. Berkley W R Corp acquired a new stake in Translational Development Acquisition during the fourth quarter worth about $3,200,000. Shaolin Capital Management LLC bought a new position in Translational Development Acquisition in the fourth quarter worth about $6,915,000. Crossingbridge Advisors LLC bought a new position in shares of Translational Development Acquisition during the fourth quarter valued at approximately $11,064,000. Finally, Westchester Capital Management LLC acquired a new stake in shares of Translational Development Acquisition during the 4th quarter worth approximately $5,277,000.

Translational Development Acquisition Price Performance

Shares of TDACU opened at $10.22 on Thursday. The company’s fifty day moving average price is $10.17. Translational Development Acquisition Corp. has a 1 year low of $10.00 and a 1 year high of $10.30.

Translational Development Acquisition Company Profile

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.